A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

No Carolina / New York

Northwell Health Implements New Screening Technology – Evolv Express

Northwell Health has implemented new comprehensive detection systems that screen for weapons and contraband at the entrances of Long Island Jewish Medical Center in New Hyde Park, South Shore University Hospital in Bay Shore and Lenox Health Greenwich Village in Manhattan as part of an effort to bring the technology to all hospitals in the health system.

The seamless walk-through system, Evolv Express, from Massachusetts-based Evolv Technology, allows for a touchless experience while screening for weapons. The screening process, monitored at each location by Northwell’s security team, is immediate and designed to avoid bottlenecking and slow lines associated with older detection screening processes and technologies.

“The safety, security and well-being of our patients, visitors and team members are our top priorities,” said Michael Dowling, Northwell’s president and CEO. “To help ensure a safe environment for all who enter our facilities – and as part of Northwell’s broader safety and security efforts – we’re trying this next generation of screening devices.”

The high-tech systems, which will also be installed at other facilities in the health system, are part of a larger Northwell initiative to maintain the safety of employees, patients and visitors. The effort also includes more resources and trainings for team members to enhance workplace safety, said Scott Strauss, vice president of security and support systems.

Northwell has hosted hundreds of trainings over the last few years that include active-shooter drills, seminars on conflict de-escalation techniques and courses on how to respond to bleeding emergencies so that team members are better prepared in case of a crisis.

“Northwell is known for its world-class health care and it’s our mission to keep patients safe with world-class security measures,” said Strauss. “The installation of this new detection system is just the latest addition to a wide range of security protocols the health system has in place to protect those in our hospitals, minimize the risk of violence and maintain a safe working environment for our team members. This technology adds just another layer of safety – and improves confidence for everyone who enters these healing spaces.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Dr. Sachita Shah, Sr. Director, Global Health, Butterfly Network, "Butterfly is proud to continue improving maternal health equity through Phase Two of the largest-scale handheld ultrasound distribution and training ever conducted in Sub-Saharan Africa. South Africa is an emerging market that continues to have disproportionately high rates of maternal mortality and stillbirth. Patients need easier access to antenatal imaging, and clinicians need better capabilities for screening high-risk conditions that lead to disproportionately worse pregnancy outcomes in rural areas in the public sector. Together with CHAI and GUSI, we can tackle this by making ultrasound much more accessible, so high-risk conditions can be identified earlier in care, which is known to improve outcomes.”
The clinical Study will enroll up to 97 patients at up to 12 European investigational sites. Completion of the study is expected this year, and results will support CE mark and pre-market approval submissions reports Vivasure Medical.
Dr. Michael Newman, Indaptus’ Founder, Chief Scientific Officer, and lead author, commented, “The new data are consistent with our preclinical animal tumor model studies and provide evidence for our hypothesis that patented Decoy bacteria can activate a wide range of innate and adaptive human immune cells involved in fighting tumors.  This aligns with what we’ve observed in our ongoing Phase 1 clinical trial of Decoy20 – broad immune activation, as evidenced by transiently increased levels of many key cytokines and chemokines following single dose administration. These findings bolster our confidence in Decoy20's potential as a multifaceted immunotherapy.”
To further understand the impact of platforms like TikTok on nutrition trends, MyFitnessPal partnered with Dublin City University on a research and experimental study that examined diet and nutrition content on TikTok. The study analyzed over 67,000 videos using Artificial Intelligence to compare them against public health and nutrition guidelines
Leveraging the power of Apple Vision Pro to seamlessly blend digital content with the physical world Osso Health brings the operating experience to life via detailed, clinically accurate workflows of common procedures.

By using this website you agree to accept Medical Device News Magazine Privacy Policy